Spectrum Pharmaceuticals, Inc. (SPPI)
(Delayed Data from NSDQ)
$9.80 USD
+0.50 (5.38%)
Updated May 3, 2019 04:00 PM ET
After-Market: $9.81 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For SPPI
-
Spectrum Pharmaceuticals (SPPI) Reports Q1 Loss, Tops Revenue Estimates
-
Spectrum Pharma: Q1 Earnings Snapshot
-
Spectrum Pharmaceuticals Reports First Quarter 2023 Financial Results and Corporate Update
-
Spectrum Pharma: Q4 Earnings Snapshot
-
Spectrum Pharmaceuticals (SPPI) Reports Q4 Loss, Tops Revenue Estimates
-
Spectrum Pharmaceuticals Reports Fourth Quarter 2022 and Full Year 2022 Financial Results and Corporate Update
-
Spectrum Pharma: Q3 Earnings Snapshot
-
Spectrum Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
-
Spectrum Pharma: Q2 Earnings Snapshot
-
Spectrum Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Corporate Update
-
Spectrum Pharmaceuticals (SPPI) Reports Q3 Loss, Misses Revenue Estimates
-
Spectrum Pharmaceuticals (SPPI) Reports Q2 Loss, Lags Revenue Estimates
-
Why Is Spectrum Pharma (SPPI) Up 6.6% Since Last Earnings Report?
-
Spectrum Pharma (SPPI) Incurs Wider-Than-Expected Q1 Loss
-
Spectrum Pharma (SPPI) Down 4.6% Since Last Earnings Report: Can It Rebound?
-
Spectrum Pharma (SPPI) Incurs Wider-Than-Expected Q4 Loss
-
What Awaits Spectrum Pharmaceuticals (SPPI) in Q4 Earnings?
-
Why Is Spectrum Pharma (SPPI) Up 23.9% Since Last Earnings Report?
-
Spectrum Pharma's (SPPI) Q3 Loss Narrows, Focus on Rolontis
-
Spectrum Pharma (SPPI) Down 0.7% Since Last Earnings Report: Can It Rebound?
-
Spectrum Pharma's (SPPI) Loss Narrows in Q2, Stock Rises
-
Spectrum Pharmaceuticals (SPPI) Reports Q2 Loss, Misses Revenue Estimates
-
Analysts Estimate Spectrum Pharmaceuticals (SPPI) to Report a Decline in Earnings: What to Look Out for
-
Why Is Spectrum Pharma (SPPI) Down 14.4% Since Last Earnings Report?
-
Spectrum Pharma (SPPI) Q1 Earnings Lag Estimates, Revenues Nil